These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16989688)

  • 61. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka.
    Gunawardena S; Ismail M; Bradley M; Karunaweera N
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):445-53. PubMed ID: 17125809
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Precontrol observations on lymphatic filariasis & geo-helminthiases in two coastal districts of rural Orrisa.
    Chhotray GP; Ranjit MR; Khuntia HK; Acharya AS
    Indian J Med Res; 2005 Nov; 122(5):388-94. PubMed ID: 16456251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Physicians' management of filarial lymphoedema and hydrocele in Pondicherry, India.
    Schellekens SM; Ananthakrishnan S; Stolk WA; Habbema JD; Ravi R
    Trans R Soc Trop Med Hyg; 2005 Jan; 99(1):75-7. PubMed ID: 15550265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mass drug administration for lymphatic filariasis elimination amidst COVID-19 pandemic in Odisha, India: A step towards achieving SDG-3.
    Sinha A; Mohapatra S; Mohanty S; Pati S; Sahoo PK
    Trop Doct; 2022 Oct; 52(4):556-559. PubMed ID: 35770893
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Major progress toward eliminating lymphatic filariasis.
    Ottesen EA
    N Engl J Med; 2002 Dec; 347(23):1885-6. PubMed ID: 12466515
    [No Abstract]   [Full Text] [Related]  

  • 70. Compliance with the mass chemotherapy program for lymphatic filariasis.
    Kasturiratne KT; Premaratne BA; Pathmeswaran A; de Silva NR; de Silva HJ
    Ceylon Med J; 2001 Dec; 46(4):126-9. PubMed ID: 12164029
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lymphatic filariasis and the women of India.
    Bandyopadhyay L
    Soc Sci Med; 1996 May; 42(10):1401-10. PubMed ID: 8735896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Community's knowledge and perceptions about filarial elephantiasis and hydrocele in coastal Orissa, India.
    Rath K; Nayak AN; Babu BV
    Asia Pac J Public Health; 2007; 19(1):28-33. PubMed ID: 17784656
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lymphatic filariasis in Madras, India.
    Hyma B; Ramesh A; Gunasekaran K
    Soc Sci Med; 1989; 29(8):983-90. PubMed ID: 2814584
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience.
    Nandha B; Sadanandane C; Jambulingam P; Das P
    Filaria J; 2007 Aug; 6():7. PubMed ID: 17718908
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of community-based lymphedema management on perceived disability among patients with lymphatic filariasis in Orissa State, India.
    Budge PJ; Little KM; Mues KE; Kennedy ED; Prakash A; Rout J; Fox LM
    PLoS Negl Trop Dis; 2013; 7(3):e2100. PubMed ID: 23516648
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Launching a lymphatic filariasis campaign in the Pacific Islands.
    Dean M
    Lancet; 2000 Jul; 356(9224):143. PubMed ID: 10963257
    [No Abstract]   [Full Text] [Related]  

  • 77. Notes from the Field: Impact of a Mass Drug Administration Campaign Using a Novel Three-Drug Regimen on Lymphatic Filariasis Antigenemia - American Samoa, 2019.
    Hast MA; Tufa A; Brant TA; Suiaunoa-Scanlan L; Camacho J; Vaifanua-Leo J; Robinson K; Dodd E; Sili B; Lees LS; Won KY; Utu F
    MMWR Morb Mortal Wkly Rep; 2020 May; 69(21):656-657. PubMed ID: 32463808
    [No Abstract]   [Full Text] [Related]  

  • 78. The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India.
    Babu BV; Nayak AN; Dhal K; Acharya AS; Jangid PK; Mallick G
    Acta Trop; 2002 Apr; 82(1):31-8. PubMed ID: 11904101
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.
    Nanda B; Krishnamoorthy K
    Trop Med Int Health; 2003 Jan; 8(1):56-9. PubMed ID: 12535251
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Community-initiated urban development: an ecological intervention.
    Semenza JC; March TL; Bontempo BD
    J Urban Health; 2007 Jan; 84(1):8-20. PubMed ID: 17123178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.